ALCAM/CD166
Activated Leukocyte Cell Adhesion Molecule
ALCAM (CD166), a cell surface glycoprotein, is a cell adhesion molecule of the immunoglobulin superfamily. ALCAM is expressed by various cell types, such as leukocytes and endothelial cells (ECs). ALCAM can bind to the T cell-expressed scavenger receptor CD6, endothelial L1CAM, and galectin-8. ALCAM regulates diverse pathophysiological processes, including T cell activation, leukocyte trafficking, and angiogenesis. ALCAM is a prognostic marker of cancers. ALCAM promotes tumor growth by controlling cell proliferation, adhesion, migration and invasion[1][2].
All Product Categories
-
ALCAM/CD166 Related Products (2)
-
Praluzatamab
0 ImagesSynonyms: CX-191; CX-2009 AntibodyPraluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
-
AT002
0 ImagesCat. No.: HY-P991532Synonyms: MEMD; EJ212/007-Cl2-5
